Bank of America’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.29M | Buy |
494,723
+25
| +0% | +$98 | ﹤0.01% | 4030 |
|
|
2025
Q4 | $1.71M | Hold |
494,698
| – | – | ﹤0.01% | 4190 |
|
|
2025
Q3 | $1.47M | Hold |
494,698
| – | – | ﹤0.01% | 5069 |
|
|
2025
Q2 | $1.47M | Hold |
494,698
| – | – | ﹤0.01% | 5016 |
|
|
2025
Q1 | $1.13M | Hold |
494,698
| – | – | ﹤0.01% | 5139 |
|
|
2024
Q4 | $1.85M | Hold |
494,698
| – | – | ﹤0.01% | 4512 |
|
|
2024
Q3 | $1.48M | Hold |
494,698
| – | – | ﹤0.01% | 4783 |
|
|
2024
Q2 | $1.44M | Hold |
494,698
| – | – | ﹤0.01% | 4666 |
|
|
2024
Q1 | $1.69M | Hold |
494,698
| – | – | ﹤0.01% | 4553 |
|
|
2023
Q4 | $1.43M | Hold |
494,698
| – | – | ﹤0.01% | 4703 |
|
|
2023
Q3 | $1.38M | Buy |
+494,698
| New | +$1.17M | ﹤0.01% | 4577 |
|
|
2022
Q2 | – | Sell |
-9,431
| Closed | -$69K | – | 8477 |
|
|
2022
Q1 | $69K | Buy |
9,431
+5,994
| +174% | +$42.7K | ﹤0.01% | 7032 |
|
|
2021
Q4 | $26K | Buy |
3,437
+3,333
| +3,205% | +$30.1K | ﹤0.01% | 7443 |
|
|
2021
Q3 | $1K | Buy |
104
+52
| +100% | +$1.02K | ﹤0.01% | 8025 |
|
|
2021
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 7659 |
|
|
2021
Q1 | $2K | Hold |
52
| – | – | ﹤0.01% | 7263 |
|
|
2020
Q4 | $1K | Sell |
52
-42
| -45% | -$485 | ﹤0.01% | 7025 |
|
|
2020
Q3 | $1K | Hold |
94
| – | – | ﹤0.01% | 6799 |
|
|
2020
Q2 | $2K | Hold |
94
| – | – | ﹤0.01% | 6689 |
|
|
2020
Q1 | $2K | Sell |
94
-1,600
| -94% | -$56.7K | ﹤0.01% | 6660 |
|
|
2019
Q4 | $199K | Buy |
1,694
+1,608
| +1,870% | +$159K | ﹤0.01% | 5642 |
|
|
2019
Q3 | $8K | Buy |
+86
| New | +$7.96K | ﹤0.01% | 6767 |
|
|
2019
Q1 | – | Sell |
-787
| Closed | -$31K | – | 7469 |
|
|
2018
Q4 | $31K | Buy |
+787
| New | +$34.3K | ﹤0.01% | 6372 |
|
|
2014
Q1 | – | Sell |
-1
| Closed | – | – | 8129 |
|
|
2013
Q4 | $0 | Buy |
+1
| New | +$819 | ﹤0.01% | 8190 |
|
Other funds holding GRCE
EP
NCM
VCM
CCM
QC